Kay B. Barnes

Salisbury, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Exploration of refined humane endpoints for melioidosis in BALB/c mice.

Exploration of refined humane endpoints for melioidosis in BALB/c mice.

Journal: Lab animal

Published: November 12, 2024

Layering vaccination with antibiotic therapy results in protection and clearance of Burkholderia pseudomallei in Balb/c mice.

Layering vaccination with antibiotic therapy results in protection and clearance of Burkholderia pseudomallei in Balb/c mice.

Journal: Infection and immunity

Published: January 30, 2024

Phage-induced efflux down-regulation boosts antibiotic efficacy.

Phage-induced efflux down-regulation boosts antibiotic efficacy.

Journal: PLoS pathogens

Published: November 16, 2023

In Vitro Activity of Novel Topoisomerase Inhibitors against Francisella tularensis and Burkholderia pseudomallei.

In Vitro Activity of Novel Topoisomerase Inhibitors against Francisella tularensis and Burkholderia pseudomallei.

Journal: Antibiotics (Basel, Switzerland)

Published: April 04, 2023

In Vitro Activity of Finafloxacin against Panels of Respiratory Pathogens.

In Vitro Activity of Finafloxacin against Panels of Respiratory Pathogens.

Journal: Antibiotics (Basel, Switzerland)

Published: April 03, 2023

The BALB/c Mouse Model for the Evaluation of Therapies to Treat Infections with Aerosolized Burkholderia pseudomallei.

The BALB/c Mouse Model for the Evaluation of Therapies to Treat Infections with Aerosolized Burkholderia pseudomallei.

Journal: Antibiotics (Basel, Switzerland)

Published: January 13, 2023

Efficacy of finafloxacin in a murine model of inhalational glanders.

Efficacy of finafloxacin in a murine model of inhalational glanders.

Journal: Frontiers in microbiology

Published: September 29, 2022

An Investigation into the Re-Emergence of Disease Following Cessation of Antibiotic Treatment in Balb/c Mice Infected with Inhalational Burkholderia pseudomallei.

An Investigation into the Re-Emergence of Disease Following Cessation of Antibiotic Treatment in Balb/c Mice Infected with Inhalational Burkholderia pseudomallei.

Journal: Antibiotics (Basel, Switzerland)

Published: September 16, 2022

Investigation of a combination therapy approach for the treatment of melioidosis.

Investigation of a combination therapy approach for the treatment of melioidosis.

Journal: Frontiers in microbiology

Published: May 02, 2022

Finafloxacin, a Novel Fluoroquinolone, Reduces the Clinical Signs of Infection and Pathology in a Mouse Model of Q Fever.

Finafloxacin, a Novel Fluoroquinolone, Reduces the Clinical Signs of Infection and Pathology in a Mouse Model of Q Fever.

Journal: Frontiers in microbiology

Published: August 18, 2021

Finafloxacin Is an Effective Treatment for Inhalational Tularemia and Plague in Mouse Models of Infection.

Finafloxacin Is an Effective Treatment for Inhalational Tularemia and Plague in Mouse Models of Infection.

Journal: Antimicrobial agents and chemotherapy

Published: November 03, 2020

Demonstration of the broad spectrum in vitro activity of finafloxacin against pathogens of biodefence interest.

Demonstration of the broad spectrum in vitro activity of finafloxacin against pathogens of biodefence interest.

Journal: Antimicrobial agents and chemotherapy

Published: October 02, 2019

Showing 1-12 of 19

Last Updated: 09/26/2026